Influenza Clinical Trial
Official title:
Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care
Verified date | April 2020 |
Source | The University of Queensland |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This project is a randomised trial in order to determine if "gamification" can result in behaviour change for healthcare workers in the residential aged care setting. The app is for Age Care and care workers at the front line who are working to protect those most vulnerable to COVID-19. There are 2 groups in this trial on group will receive current and accurate information from an app. The other group will receives the app with the addition of a gamification competent, this will include rewarding experiences for staff doing safety behaviours and wellbeing behaviours. The purpose of the gamification is to create a calming and reassuring experience that injects positivity and joy where possible during this stressful time.
Status | Terminated |
Enrollment | 34 |
Est. completion date | August 26, 2020 |
Est. primary completion date | August 26, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Age Health Care Worker Exclusion Criteria: - |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
The University of Queensland |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group | Compare the number of sick leave prior to users utilising the app and at the end of the 4 weeks between the arms | 4 weeks | |
Secondary | To compare handwashing behaviour | Compare the amount of soap/sanitiser used between the arms | 4 weeks | |
Secondary | To compare self-testing rates | Compare the number of self tests between the two arms | 4 weeks | |
Secondary | To compare the level of surface wipe down | Compare the amount of wipes/disinfectant used between the two arms | 4 weeks | |
Secondary | To compare number of COVID-19 tests completed in Facilities | Compare the number of COVID-19 tests between the two arms | 4 weeks | |
Secondary | To compare the number of COVID 19 infections in facilities | Compare the number of COVID-19 infections between the arms | 4 weeks | |
Secondary | To compare the other types of outbreaks (Flu, gastroenteritis) | Compare the number of flu and gastroenteritis outbreaks between the arms | 4 weeks | |
Secondary | To compare the awareness of COVID 19 training available to workers in the facilities | Compare the COVID 19 training between the two arms, this is via a self reported survey | 4 weeks | |
Secondary | To compare the awareness of PPE training available to workers in the facilities | Compare the awareness of PPE training of the workers in the two arms, this is captured in self reported survey | 4 weeks | |
Secondary | To compare the levels of PPE material used in | Compare the amount of PPE used between the arms | 4 weeks | |
Secondary | To compare the wellbeing and self-efficacy of the two groups | Compare the wellbeing and self-efficacy between the two arms, this is captured in a self reported survey. | 4 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05523089 -
The Effectiveness of CD388 to Prevent Flu in an Influenza Challenge Model in Healthy Adults
|
Phase 2 | |
Completed |
NCT05009251 -
Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake
|
N/A | |
Completed |
NCT03282240 -
Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Participants ≥65 Years in the US
|
Phase 3 | |
Completed |
NCT00968526 -
Study to Evaluate Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
Completed |
NCT00968539 -
Study to Evaluate the Immunogenicity & Safety of an Investigational Influenza Vaccine (H1N1) in Adults
|
Phase 3 | |
Completed |
NCT00971425 -
Evaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)
|
Phase 3 | |
Completed |
NCT05525494 -
Patient Portal Flu Vaccine Reminders (5)
|
N/A | |
Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
Completed |
NCT04695717 -
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam
|
Phase 3 | |
Completed |
NCT05012163 -
Lottery Incentive Nudges to Increase Influenza Vaccinations
|
N/A | |
Completed |
NCT04109222 -
Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively
|
Phase 4 | |
Completed |
NCT03888989 -
Response to Influenza Vaccine During Pregnancy
|
Phase 1 | |
Completed |
NCT02587221 -
Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared to Non-influenza Vaccine Comparator in Adults ≥ 65 Years of Age
|
Phase 3 | |
Completed |
NCT03453801 -
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
|
Phase 1 | |
Completed |
NCT01440387 -
A Study of Immunogenicity and Safety of GSK Biologicals' Influenza Vaccine FLU-Q-QIV in Adults Aged 18 Years and Older
|
Phase 3 | |
Terminated |
NCT01195779 -
Trial to Evaluate Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine GSK2584786A in Healthy Children
|
Phase 2 | |
Completed |
NCT03321968 -
Lot-to-lot Consistency of a Plant-Derived Quadrivalent Virus-Like Particles Influenza Vaccine in Healthy Adults
|
Phase 3 | |
Completed |
NCT00972517 -
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Children
|
Phase 3 | |
Completed |
NCT04570904 -
Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
|
||
Recruiting |
NCT03331991 -
Prevention of Influenza and Other Wintertime Respiratory Viruses Among Healthcare Professionals in Israel
|
N/A |